{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Analysis of the China cohort was performed to evaluate the consistency of efficacy and safety in Chinese patients with the global cohort in order to meet regulatory requirements and was not powered for a formal assessment of statistical significance."},"pointOfContact":{"email":"information.center@astrazeneca.com","organization":"AstraZeneca","phone":"1-877-240-9479","title":"Global Clinical Lead"}}